DSAM Partners London Ltd bought a new stake in shares of Monsanto Company (NYSE:MON) in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 16,970 shares of the basic materials company’s stock, valued at approximately $2,009,000.
Several other institutional investors have also added to or reduced their stakes in the company. BlackRock Inc. boosted its stake in shares of Monsanto by 2,390.1% during the 1st quarter. BlackRock Inc. now owns 26,192,816 shares of the basic materials company’s stock valued at $2,965,029,000 after buying an additional 25,140,936 shares during the last quarter. State Street Corp boosted its stake in shares of Monsanto by 1.2% during the 1st quarter. State Street Corp now owns 20,153,966 shares of the basic materials company’s stock valued at $2,281,433,000 after buying an additional 234,582 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its stake in shares of Monsanto by 3.6% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 14,299,502 shares of the basic materials company’s stock valued at $1,618,703,000 after buying an additional 499,639 shares during the last quarter. Flossbach Von Storch AG boosted its stake in shares of Monsanto by 7.5% during the 2nd quarter. Flossbach Von Storch AG now owns 4,397,000 shares of the basic materials company’s stock valued at $520,429,000 after buying an additional 307,600 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in shares of Monsanto by 7.7% during the 1st quarter. Geode Capital Management LLC now owns 4,125,879 shares of the basic materials company’s stock valued at $466,359,000 after buying an additional 295,452 shares during the last quarter. Institutional investors own 74.79% of the company’s stock.
In other Monsanto news, EVP Robert T. Fraley sold 52,410 shares of the business’s stock in a transaction on Monday, July 10th. The stock was sold at an average price of $117.95, for a total value of $6,181,759.50. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Steven Mizell sold 11,300 shares of the business’s stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total value of $1,339,841.00. Following the completion of the transaction, the executive vice president now directly owns 55,011 shares in the company, valued at approximately $6,522,654.27. The disclosure for this sale can be found here. 0.79% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY NOTICE: This piece was reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://ledgergazette.com/2017/09/17/16970-shares-in-monsanto-company-mon-acquired-by-dsam-partners-london-ltd.html.
Shares of Monsanto Company (NYSE MON) traded up 0.57% on Friday, hitting $118.27. The stock had a trading volume of 2,233,896 shares. The firm has a 50 day moving average price of $117.25 and a 200-day moving average price of $116.44. Monsanto Company has a 52 week low of $97.35 and a 52 week high of $118.97. The company has a market cap of $51.96 billion, a price-to-earnings ratio of 25.54 and a beta of 1.07.
Monsanto (NYSE:MON) last announced its quarterly earnings results on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.19. The business had revenue of $4.23 billion for the quarter, compared to analyst estimates of $4.18 billion. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. Monsanto’s quarterly revenue was up 1.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.17 EPS. Analysts anticipate that Monsanto Company will post $4.89 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be paid a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 1.83%. The ex-dividend date is Thursday, October 5th. Monsanto’s dividend payout ratio is currently 46.75%.
Several equities analysts have recently commented on the company. UBS AG cut Monsanto from a “positive” rating to a “neutral” rating in a research note on Tuesday, June 27th. BidaskClub cut Monsanto from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Zacks Investment Research cut Monsanto from a “buy” rating to a “hold” rating in a research note on Wednesday, June 21st. Piper Jaffray Companies set a $128.00 price objective on Monsanto and gave the stock a “buy” rating in a research note on Friday, August 11th. Finally, Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price objective on the stock in a research note on Tuesday, June 27th. Ten research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Monsanto currently has an average rating of “Hold” and an average price target of $124.09.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.